FMR CORP 13D/13G Filings for ProQR Therapeutics N.V. (PRQR)

FMR CORP 13D and 13G filings for ProQR Therapeutics N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-09
12:31 pm
Sale		 2023-02-09 13G ProQR Therapeutics N.V.
PRQR		 FMR CORP 0
0.000%		 -4,462,438decrease
(Position Closed)		 Filing
2022-02-09
10:24 am
Purchase		 2022-02-08 13G ProQR Therapeutics N.V.
PRQR		 FMR CORP 4,462,438
6.271%		 4,224,522increase
(+1775.64%)		 Filing